Posizioni attive di Cole Ikkala
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| RADIUS HEALTH, INC. | Corporate Officer/Principal | 01/07/2020 | - |
Storia della carriera di Cole Ikkala
Precedenti posizioni note di Cole Ikkala
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| NVN LIQUIDATION, INC. | Contatto Relazioni con gli Investitori | - | - |
| Public Communications Contact | - | - |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
Posizioni
| Investor Relations Contact | 1 |
| Public Communications Contact | 1 |
| Corporate Officer/Principal | 1 |
Settori
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| NVN LIQUIDATION, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- Cole Ikkala
- Esperienza
